MLKL and cancer: Given the pivotal role of MLKL in necroptosis, one possible underlying mechanism for the association between low MLKL expression levels with poor prognosis of cancer patients may be the result of decreased necroptosis signaling, leading to the resistance to death for cancer cells in these patients.